Neurotrophic Keratitis - Global Market Outlook (2018-2027)

   |      |      |  

Neurotrophic Keratitis - Global Market Outlook (2018-2027)

"The Global Neurotrophic Keratitis Market is accounted for $60.56 million in 2018 and is expected to reach $279.06 million by 2027 growing at a CAGR of 18.5% during the forecast period. Rising reported cases and surge in investments in research and clinical study and product approvals are the major factors propelling the market growth. However, high cost of treatment is hampering the market growth.

Neurotrophic keratitis is an orphan disease which is mainly caused by the damage of the fifth cranial nerve from the trigeminal nucleus to the nerve endings present in the eye corneal region.The treatment method is implemented as per the different stages of the disease.

Based on the treatment, the drugs segment is going to have a lucrative growth during the forecast period as artificial tears are prescribed for all the stages due to its ability to provide wetness and lubrication to the corneal surface and ensure cleanliness. By geography, North America is going to have a lucrative growth during the forecast period owing to rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, and presence of key players.

Some of the key players profiled in the Neurotrophic Keratitis Market include Walgreens, ReGenTree, LLC, Novartis AG, Dompefarmaceutici S.p.A., CooperVision, Bayer AG, Bausch & Lomb Incorporated, Allergan, Plc., Abbott Laboratories, Inc. and Johnson & Johnson.

Treatments Covered:
• Drugs
• Surgical Intervention

Stages Covered:
• Stage I
• Stage II
• Stage III

Applications Covered:
• Clinic
• Hospital

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Neurotrophic Keratitis Market, By Treatment
5.1 Introduction
5.2 Drugs
5.2.1 Topical Antibiotics
5.2.2 RGN-259
5.2.3 Recombinant Human Nerve Growth Factors Eye Drop
5.2.4 Oral Antibiotics
5.2.5 Bandage Contact Lens
5.2.6 Artificial Tears
5.3 Surgical Intervention
5.3.1 Tarsorrhaphy
5.3.2 Amniotic Membrane Transplantation

6 Global Neurotrophic Keratitis Market, By Stage
6.1 Introduction
6.2 Stage I
6.3 Stage II
6.4 Stage III

7 Global Neurotrophic Keratitis Market, By Application
7.1 Introduction
7.2 Clinic
7.3 Hospital

8 Global Neurotrophic Keratitis Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Walgreens
10.2 ReGenTree LLC
10.3 Novartis AG
10.4 Dompe farmaceutici S.p.A.
10.5 CooperVision
10.6 Bayer AG
10.7 Bausch & Lomb Incorporated
10.8 Allergan Plc
10.9 Abbott Laboratories Inc
10.10 Johnson & Johnson

List of Tables
Table 1 Global Neurotrophic Keratitis Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)
Table 3 Global Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)
Table 4 Global Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN)
Table 5 Global Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)
Table 6 Global Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
Table 7 Global Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)
Table 8 Global Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
Table 9 Global Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN)
Table 10 Global Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
Table 11 Global Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN)
Table 12 Global Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
Table 13 Global Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)
Table 14 Global Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)
Table 15 Global Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)
Table 16 Global Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)
Table 17 Global Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)
Table 18 Global Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)
Table 19 Global Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)
Table 20 North America Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)
Table 21 North America Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)
Table 22 North America Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)
Table 23 North America Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN)
Table 24 North America Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)
Table 25 North America Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
Table 26 North America Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)
Table 27 North America Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
Table 28 North America Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN)
Table 29 North America Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
Table 30 North America Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN)
Table 31 North America Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
Table 32 North America Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)
Table 33 North America Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)
Table 34 North America Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)
Table 35 North America Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)
Table 36 North America Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)
Table 37 North America Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)
Table 38 North America Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)
Table 39 Europe Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)
Table 40 Europe Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)
Table 41 Europe Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)
Table 42 Europe Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN)
Table 43 Europe Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)
Table 44 Europe Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
Table 45 Europe Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)
Table 46 Europe Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
Table 47 Europe Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN)
Table 48 Europe Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
Table 49 Europe Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN)
Table 50 Europe Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
Table 51 Europe Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)
Table 52 Europe Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)
Table 53 Europe Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)
Table 54 Europe Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)
Table 55 Europe Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)
Table 56 Europe Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)
Table 57 Europe Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)
Table 58 Asia Pacific Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)
Table 59 Asia Pacific Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)
Table 60 Asia Pacific Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)
Table 61 Asia Pacific Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN)
Table 62 Asia Pacific Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)
Table 63 Asia Pacific Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
Table 64 Asia Pacific Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)
Table 65 Asia Pacific Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
Table 66 Asia Pacific Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN)
Table 67 Asia Pacific Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
Table 68 Asia Pacific Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN)
Table 69 Asia Pacific Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
Table 70 Asia Pacific Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)
Table 71 Asia Pacific Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)
Table 72 Asia Pacific Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)
Table 73 Asia Pacific Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)
Table 74 Asia Pacific Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)
Table 75 Asia Pacific Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)
Table 76 Asia Pacific Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)
Table 77 South America Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)
Table 78 South America Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)
Table 79 South America Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)
Table 80 South America Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN)
Table 81 South America Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)
Table 82 South America Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
Table 83 South America Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)
Table 84 South America Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
Table 85 South America Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN)
Table 86 South America Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
Table 87 South America Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN)
Table 88 South America Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
Table 89 South America Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)
Table 90 South America Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)
Table 91 South America Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)
Table 92 South America Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)
Table 93 South America Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)
Table 94 South America Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)
Table 95 South America Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)
Table 96 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Country (2017-2027) ($MN)
Table 97 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Treatment (2017-2027) ($MN)
Table 98 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Drugs (2017-2027) ($MN)
Table 99 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Topical Antibiotics (2017-2027) ($MN)
Table 100 Middle East & Africa Neurotrophic Keratitis Market Outlook, By RGN-259 (2017-2027) ($MN)
Table 101 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Recombinant Human Nerve Growth Factors Eye Drop (2017-2027) ($MN)
Table 102 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Oral Antibiotics (2017-2027) ($MN)
Table 103 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Bandage Contact Lens (2017-2027) ($MN)
Table 104 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Artificial Tears (2017-2027) ($MN)
Table 105 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Surgical Intervention (2017-2027) ($MN)
Table 106 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Tarsorrhaphy (2017-2027) ($MN)
Table 107 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Amniotic Membrane Transplantation (2017-2027) ($MN)
Table 108 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Stage (2017-2027) ($MN)
Table 109 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Stage I (2017-2027) ($MN)
Table 110 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Stage II (2017-2027) ($MN)
Table 111 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Stage III (2017-2027) ($MN)
Table 112 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Application (2017-2027) ($MN)
Table 113 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Clinic (2017-2027) ($MN)
Table 114 Middle East & Africa Neurotrophic Keratitis Market Outlook, By Hospital (2017-2027) ($MN)
"

Neurotrophic Keratitis - Global Market Outlook (2018-2027)

.